Long term efficacy and safety of atorvastatin in the treatment of severe type III and combined dyslipidaemia

Background: Fibric acid derivatives and HMG-CoA reductase inhibitors are effective in combination for treating patients with familial dysbetalipoproteinaemia and severe combined dyslipidaemia, but combination therapy affects compliance and increases the risk of side effects. Aim: To evaluate the eff...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: van Dam, M, Zwart, M, de Beer, F, Smelt, A H M, Prins, M H, Trip, M D, Havekes, L M, Lansberg, P J, Kastelein, J J P
Formato: Artigo
Idioma:Inglês
Publicado em: Copyright 2002 by Heart 2002
Assuntos:
Cardiovascular Medicine
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC1767327/
https://ncbi.nlm.nih.gov/pubmed/12181212
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados